3篇
您的检索式：作者名="Massimo Brunelli"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 意大利地中海隼(Falco biarmicus feldeggii)繁殖种群的景观尺度空间分布显示文摘地中海隼(Falco biarmicus feldeggii)是欧洲濒危程度最高的物种之一。其全球数量估计不超过几百对,不均匀分布于西西里至里海的广阔而片断化的地区。最近统计表明,西西里地中海隼在全部种群数量中占很大比例(>25%)。因此,意大利政府提出一项国家行动计划。在这一计划框架下,我们在意大利进行了首次地中海隼种群数量的全国调查(2003~2004年)。本研究的地理范围包括地中海隼的整个繁殖区,即西西里和意大利半岛(n=2909栅格单元,10km×10km)。另外,我们尽量考虑了以往(1993~2001年)区域调查的结果。我们对各个繁殖亚群的大小和分布进行评估,鉴别在景观尺度上与巢址空间分布相关的主要环境特征。在184个栅格单元(全部栅格地图的6.4%)中发现有地中海隼的存在,但同一繁殖期内地中海隼数量估计不超过140~172对(其中70~80对分布于西西里)。大陆繁殖栅格的隔离程度较高,而西西里地区的单元更为密集。海拔高度是意大利单元聚集性的主要影响因素;另外气候、降水量和植被等环境因素对此也有重要影响。本研究表明保护区内的处于繁殖期的地中海隼数量较少(23%~28%),意大利政府的保护措施还不够完善。在适于地中海隼巢址不规则空间聚集的优先性生境保护方面,多个小型、分散分布的特定保育区(SAC)优于大型特定保护区(SPA)。 | Alessandro Andreotti Giovanni Leonardi Maurizio Sarà Massimo Brunelli Lorenzo De Lisio Augusto De Sanctis Mauro Magrini Riccardo Nardi Paolo Perna Antonio Sigismondi 梁虹 | 2008 | AMBIO-人类环境杂志2008，37，6： | 1 |
| 2 | Edmonton symptom assessment scale: Italian validation in two palliative care settings显示文摘 | Cecilia Moro Cinzia Brunelli Guido Miccinesi Mauro Fallai Piero Morino Massimo Piazza Roberto Labianca Carla Ripamonti | 2006 | Supportive Care in Cancer2006，，1： | 1 |
| 3 | Risk factors of extraneural spreading in astrocytomas and oligodendrogliomas in donors with gliomas: A systematic review显示文摘BACKGROUND Patients with a history of primary brain tumors can be eligible for organ donation under extended criteria.The risk assessment of tumor transmission via organ transplant in primary brain tumors is primarily based on the assessment of tumor histotype and grade.Previous surgeries,chemo-/radiotherapy,and ventriculoperitoneal shunt placement can lead to a disruption of the blood-brain barrier,concurring to an increase in the transmission risk.AIM To investigate the role of tumor transmission risk factors in donors with oligodendrogliomas and astrocytomas.METHODS We searched PubMed and EMBASE databases for studies reporting extraneural spreading of oligoden-drogliomas and astrocytomas and extracted clinical-pathological data on the primary tumor histotype and grade,the elapsed time from the diagnosis to the onset of metastases,sites and number of metastases,prior surgeries,prior radiotherapy and/or chemotherapy,ventriculoatrial or ventriculo-peritoneal shunt placement,and the presence of isocitrate dehydrogenase 1/2 mutation and 1p/19q codeletion.Statistical analysis was performed using R software.Statistical correlation between chemotherapy or radiotherapy and the presence of multiple extra-central nervous system metastases was analyzed usingχ2 and Fischer exact test.The Kaplan-Meier method was used to evaluate the presence of a correlation between the metastasis-free time and:(1)Localization of metastases;(2)The occurrence of intracranial recurrences;and(3)The occurrence of multiple metastases.RESULTS Data on a total of 157 patients were retrieved.The time from the initial diagnosis to metastatic spread ranged from 0 to 325 mo in patients with oligodendrogliomas and 0 to 267 mo in those with astrocytomas.Respectively,19%and 39%of patients with oligodendroglioma and astrocytoma did not receive any adjuvant therapy.The most frequent metastatic sites were bone,bone marrow,and lymph nodes.The lungs and the liver were the most commonly involved visceral sites.There was no significant correlation between the occurrence of multiple metastases and the administration of adjuvant chemo-/radiotherapy.Patients who developed intracranial recurrences/metastases had a significantly longer extraneural metastasis-free time compared to those who developed extraneural metastases in the absence of any intra-central nervous system spread.CONCLUSION A long follow-up time does not exclude the presence of extraneural metastases.Therefore,targeted imaging of bones and cervical lymph nodes may improve safety in the management of these donors. | Serena Ammendola Valeria Barresi Elena Bariani Ilaria Girolami Antonia D’Errico Matteo Brunelli Massimo Cardillo Letizia Lombardini Amedeo Carraro Ugo Boggi Owen Cain Desley Neil Albino Eccher | 2022 | World Journal of Transplantation2022，12，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员